6160.HK · BEONE MEDICINES
Hong Kong · RS rating 80 · As of 2026-10-14
| Price | 209.40 HKD |
|---|---|
| 1-day change | -2.3% |
| RS rating (overall / 1M / 3M / 12M) | 80 / 57 / 77 / 69 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 48 / 45 / 50 |
| Industry group (rank) | Pharma & Biotech (30) |
| EPS growth Q/Q | +6.7% |
| Sales growth Q/Q | +12.7% |
| Distance from 52-week high | +8.6% |
| Market cap (USD) | $39.5B |